PMA
P120020: SUPERA PERIPHERAL STENT SYSTEM
FDA PMA · STENT, SUPERFICIAL FEMORAL ARTERY · Abbott Vascular (Idef Technologies Inc)
Key facts
| PMA number | P120020 |
|---|---|
| Trade name | SUPERA PERIPHERAL STENT SYSTEM |
| Generic name | STENT, SUPERFICIAL FEMORAL ARTERY |
| Applicant | Abbott Vascular (Idef Technologies Inc) |
| Owner/operator | ABBOTT LABORATORIES |
| Product code | NIP |
| Approval date | Mar 28, 2014 |
| Docket number | 14M-0434 |
| Notice date | Apr 21, 2014 |
| Establishment registration | 2939561 |
| FEI number | 3004635528 |
At a glance
- 10–99 Supplements
- Mar 20, 2026 Latest supplement decision
- No Withdrawn
- Yes Summary of safety and effectiveness on file
- None UDI device identifiers (GUDID)
- None MAUDE adverse event reports
- None Recall events
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA approvals
Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: